NLRP3 and breast cancer: According to our observations, treatment with inhibitor of NLRP3 inflammasome or caspase-1 (MCC950 or Ac-YVAD-cmk) showed to inhibit breast cancer cells growth in MCF-7 and T47D breast cancer cells.